A detailed history of Premier Path Wealth Partners, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 12,500 shares of AVXL stock, worth $131,125. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,500
Previous 12,500 -0.0%
Holding current value
$131,125
Previous $71 Million 89.08%
% of portfolio
0.02%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$5.04 - $9.95 $63,000 - $124,374
12,500 New
12,500 $116 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $818M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Premier Path Wealth Partners, LLC Portfolio

Follow Premier Path Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Path Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Path Wealth Partners, LLC with notifications on news.